» Articles » PMID: 40000557

Mouse Mesenchymal Stem Cell-derived Exosomal MiR-205-5p Modulates LPS-induced Macrophage Polarization and Alleviates Lung Injury by Regulating the USP7/FOXM1 Axis

Overview
Publisher Springer
Specialty Pharmacology
Date 2025 Feb 25
PMID 40000557
Authors
Affiliations
Soon will be listed here.
Abstract

Exosomal microRNAs produced from mesenchymal stem cells (MSCs) are crucial in the management of acute lung injury (ALI). In this work, mMSCs separated from bone marrow were used to extract exosomes (MSC-Exos). MSC-Exos treatment attenuated pathological changes and scores, and edema in ALI mice. Also, MSC-Exos administration modulated the concentrations of inflammatory factors as well as the macrophage polarization both in vivo and in vitro. Upregulation of miR-205-5p in MSC-Exos regulated the macrophage polarization and the contents of inflammatory factors in animal and cell models. MiR-205-5p targeted USP7, and negatively modulated the expression of USP7. USP7 interacted with FOXM1, and reduced the ubiquitination degradation of FOXM1. MSC-derived exosomal miR-205-5p modulated ubiquitination of FOXM1 by targeting USP7. The ameliorative effect of MSC-Exos on the macrophage polarization and the inflammatory factors release was reversed with the overexpression of USP7 in animal and cell models. Collectively, MSC-derived exosomal miR-205-5p regulated lipopolysaccharide (LPS)-induced macrophage polarization and alleviated lung injury by the USP7/FOXM1 axis, which developed a potential target for the treatment of ALI.

References
1.
Nieman G, Andrews P, Satalin J, Wilcox K, Kollisch-Singule M, Madden M . Acute lung injury: how to stabilize a broken lung. Crit Care. 2018; 22(1):136. PMC: 5968707. DOI: 10.1186/s13054-018-2051-8. View

2.
Nieman G, Gatto L, Andrews P, Satalin J, Camporota L, Daxon B . Prevention and treatment of acute lung injury with time-controlled adaptive ventilation: physiologically informed modification of airway pressure release ventilation. Ann Intensive Care. 2020; 10(1):3. PMC: 6944723. DOI: 10.1186/s13613-019-0619-3. View

3.
Bellani G, Laffey J, Pham T, Fan E, Brochard L, Esteban A . Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. JAMA. 2016; 315(8):788-800. DOI: 10.1001/jama.2016.0291. View

4.
Alessandri F, Pugliese F, Ranieri V . The Role of Rescue Therapies in the Treatment of Severe ARDS. Respir Care. 2017; 63(1):92-101. DOI: 10.4187/respcare.05752. View

5.
Xiong B, Wang C, Tan J, Cao Y, Zou Y, Yao Y . Statins for the prevention and treatment of acute lung injury and acute respiratory distress syndrome: A systematic review and meta-analysis. Respirology. 2016; 21(6):1026-33. DOI: 10.1111/resp.12820. View